Glucocorticoid induced osteoporosis;Glukokortikoid-induzierte osteoporose

Zeitschrift fur Rheumatologie

Volumn 66, Issue 2, 2007, Pages 129-138

  Lange, U ^a   Muller Ladner U ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

DVO guidelines; Glucocorticoid medication; Osteoporosis

Indexed keywords

BECLOMETASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISOLONE;

BONE DENSITY; CUSHING SYNDROME; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; WORLD HEALTH ORGANIZATION;

ANTI-INFLAMMATORY AGENTS; GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 33947533380     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-007-0151-y     Document Type: Review

References (19)

1. Bartl R, Bartl C (Hrsg) (2004) Osteoporose-Manual. Diagnostik, Prävention und Therapie. Springer, Heidelberg Berlin
2. Bestehorn K, Zink A, Dreher R (2002) Arbeitsgemeinschaft Regionaler Kooperativer Rheumazentren in der Deutschen Gesellschaft für Rheumatologie. Pharmakotherapie bei postmenopausaler Osteoporose. Z Ärztl Fortbild Qualitätsich 96: 699-704
3. Cino M, Greenberg GR (2002) Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisolone, and nonsteroid therapy. Am J Gastroenterol 97: 915-921
4. Frediani B, Falsetti P, Bisogno S et al. (2004) Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study. J Rheumatol 31: 1083-1087
5. Halpern MT, Schmier JK, Van Kerkhove MD et al. (2004) Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Ann Allergy Asthma Immunol 92: 201-207
6. Hofbauer LC, Heufelder AE (2001) Role of receptor activator of nuclear factor-?B ligand and osteoprotegerin in bone cell biology. J Mol Med 79: 243-253
7. Kanis JA, Johansson H, Oden A et al. (2004) Meta-analysis of prior corticosteroid use and fracture risk. J Bone Min Res 19: 893-899
8. Manelli F, Giustina A (2000) Glucocorticoid-induced osteoporosis. Trends Endocrinol Metab 11: 79-85
9. Prophylaxe, Diagnostik und Therapie der glukokortikoid-induzierten Osteoporose. Langfassung (2006) S3-Leitlinie des Dachverbandes der Deutschsprachigen Wissenschaftlihen Gesellschaften. Online Version (http: //www.dv-osteologie.org oder http: //www.luther-haus.de/osteo/leitlinien-dvo)
10. Ringe J (2000) Osteoporose. In: Miehle W, Fehr K, Schattenkirchner M, Tillmann K (Hrsg) Rheumatologie in Praxis und Klinik. Thieme, Stuttgart New York, S 1207-1218
11. Rubin MR, Bilezikian JP (2002) Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. J Clin Endocrinol Metab 87: 4033-4041
12. Solomon DH, Katz JN, Jacobs JP et al. (2002) Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 46: 3136-3142
13. Solomon DH, Brookhart MA, Gandhi TK et al. (2004) Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physican, and practice setting characteristics. Am J Med 117: 919-924
14. Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporosis Int 15: 323-328
15. Everdingen AA van, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW (2003) Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects in bone mineral denisty and fractues? Clin Exp Rheumatol 21: 155-160
16. Staa TP van, Leufkens HGM, Abenhaim L et al. (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatol 39: 1383-1389
17. Staa TP van, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int 13: 777-787
18. Staa TP van, Leufkens HGM, Abenhaim L et al. (2000) Use of oral corticosteroids and risk of fracture. J Bone Min Res 15: 993-1000
19. Vestergaard P, Olsen ML, Paaske Johnsen S et al. (2003) Corticosteroid use and risk of hip fracture: a populatio-based case-control study in Denmark. J Intern Med 245: 486-493